Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.

Alain WeillPierre NguyenMoujahed LabidiBenjamin CadierThibault PasseriLise DuranteauAnne-Laure BernatIsabelle YoldjianSylvie FontanelSébastien FroelichJoel Coste

Published in: BMJ (Clinical research ed.) (2021)

A strong dose-effect relation was observed between use of cyproterone acetate and risk of intracranial meningiomas. A noticeable reduction in risk was observed after discontinuation of treatment.

Keyphrases

high dose
optic nerve
low dose
polycystic ovary syndrome
stem cell transplantation
type diabetes
pregnant women
combination therapy
metabolic syndrome
adipose tissue
cervical cancer screening